Introducing Scancell's New Facilities Wednesday 24 November 2021 13:01 Categories: Media Coverage News Year - 2021
COVID- 19: Vaccine with 'double punch' in progress Monday 15 February 2021 13:30 Categories: Media Coverage News Year - 2021
COVID-19: New vaccine in development has 'insurance' against coronavirus mutations To download click here Monday 15 February 2021 10:00 Categories: Media Coverage News Year - 2021
SKY News: Interview with Professor Lindy Durrant For further information click here Friday 12 June 2020 12:00 Categories: Covid-19 Media Coverage Year - 2020
Antibody collaboration deal for Scancell CEO Cliff Holloway tells Proactive London why its antibody collaboration deal is significant and details how it complements Scancell's existing antibody technology. He also explains what is unique about Scancell's antibody pipeline. Thursday 5 September 2019 08:47 Categories: AvidiMab Interviews Media Coverage News Year - 2019
Scancell hails first antibody collaboration deal The company is teaming up with an unnamed "major player" in the world of antibodies. [View Article] Wednesday 4 September 2019 05:05 Categories: AvidiMab Media Coverage News Year - 2019
Scancell Holdings lays groundwork for pivotal year A £3.9mln injection from the life sciences fund Vulpes will effectively bankroll the latest R&D. [View article] Tuesday 20 August 2019 13:00 Categories: Media Coverage News SCIB1 Year - 2019
Scancell to begin UK arm of phase II skin cancer trial ‘immediately’ Discussions with US regulators have taken longer than expected, so Scancell will now focus its efforts on completing the UK arm of the trial before re-submitting its US application at a later date. [View article] Monday 19 August 2019 13:00 Categories: Media Coverage News SCIB1 Year - 2019
Scancell back in the clinic with a phase II trial of its flagship skin cancer treatment [View interview] Monday 19 August 2019 13:00 Categories: Interviews Media Coverage News SCIB1 Year - 2019
Scancell on verge of recruiting patients with advanced melanoma for UK clinical trials The immunotherapy specialist gave an update on progress for a “busy and productive” half-year. [View article] Monday 1 July 2019 13:00 Categories: Media Coverage Modi-1 News Year - 2019